immatics biotechnologies GmbH (4A3) — Financial Flexibility Index
immatics biotechnologies GmbH (4A3) has a Financial Flexibility Index of -0.74x as of December 2025. Free cash flow of €-57.64 Million (operating CF €-58.66 Million minus capex €1.03 Million) represents -1% of total liabilities (€78.24 Million). Also explore net asset growth rate of immatics biotechnologies GmbH to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
immatics biotechnologies GmbH Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for immatics biotechnologies GmbH across 7 annual periods. Check 4A3 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for immatics biotechnologies GmbH (2019–2025)
Year-by-year free cash flow to debt coverage for immatics biotechnologies GmbH. For the full company profile including market capitalisation, see market cap of immatics biotechnologies GmbH.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.17x | €-169.82 Million | €-176.63 Million | €78.24 Million | ▼ -86.0% |
| 2024 | -1.17x | €-141.55 Million | €-158.03 Million | €121.30 Million | ▼ -775.9% |
| 2023 | 0.17x | €49.19 Million | €18.23 Million | €284.88 Million | ▼ -68.3% |
| 2022 | 0.54x | €105.87 Million | €100.13 Million | €194.66 Million | ▼ -22.2% |
| 2021 | 0.70x | €105.24 Million | €100.13 Million | €150.58 Million | ▼ -2.3% |
| 2020 | 0.72x | €107.55 Million | €100.13 Million | €150.39 Million | ▲ +71.3% |
| 2019 | 0.42x | €73.11 Million | €70.97 Million | €175.11 Million | — |